Active Ingredient(s): Carglumic Acid
FDA Approved: * March 18, 2010
Pharm Company: * R & R REGISTRATIONS INC
Category: Hyperammonemia

Carglumic acid, sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia.[1][4][5] Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) activator.[1] The most common adverse effects include vomiting, abdominal pain, pyrexia (fever), and tonsillitis, anemia, diarrhea, ear infection, other infections, nasopharyngitis, decreased hemoglobin levels, and headache.[1] It was a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Carbaglu 80 mg/ml Oral Suspension
NDC: 52276-312
Orphan Europe, Sarl

Popular Topics

Carbaglu Availability

Is Carbaglu available in the USA?...